---
title: "CONSORT Diagram"
authors: 
  - "Kellen Stark"
  - "Matthew Hoctor, PharmD"
institute: "Oregon Health & Science University-Portland State University, School of Public Health"
date: "`r format(Sys.time(), '%d %B, %Y')`"

toc: TRUE
toc-depth: 2
toc-location: left
toc-title: Contents

code-fold: TRUE
code-overflow: wrap
code-link: TRUE

format:
  html:
    mermaid: 
      theme: default

editor: source
---

# CONSORT Diagram

```{mermaid}
flowchart TB
  H[Enrollment] ----> I
  I[Allocation] -->   J
  J[Followup  ] -->   K
  K[Analysis  ] -->   L
  L[Endpoints ] -->   M
  M[Family 1 <br>Tests] ---> N
  N[Family 2 <br>Test?]

  subgraph Enrollment
    H
    A([FQHC patient population, 25M<br>assessed for eligibility<br>n = 25M?]) -->|Meets inclusion criteria<br>i.e. has HTN, on HCTZ<br>n = 5M?| B
    B(Primary provider consents<br>Provider informed of exclusion criteria<br>and does not contact excluded patients<br>n = 1.6M?) -->|Provider requests and receives consent <br>from patient<br>n=0.5M?| C{Patient<br>randomized<br>N = 23,508+}
  end
    C -->|Switch to<br>Indapamide| D1(Indapamide arm<br>n = ?)
    C -->|HCTZ<br>Continuation| E1(Continuation of HCTZ<br>n = ?)
    C -->|Switch to<br>Chlorthalidone| F1(Chlorthalidone arm<br>n = ?)
    D1 --> D2(Loss to followup<br>n =  15,672?)
    D2 --> D3(Patient time accrues <br>3,9180+ patient-years?)
    D3 --> D4(Primary endpoint occurs<br>n = 3,506+?)
  

    E1 --> E2(Loss to followup<br>n =  15,672?)
    E2 --> E3(Patient time accrues <br>39,180+ patient-years?)
    E3 --> E4(Primary endpoint occurs<br>n = 3,506+?)

    F1 --> F2(Loss to followup<br>n = 15,672?)
    F2 --> F3(Patient time accrues <br>39,180+ patient-years?)
    F3 --> F4(Primary endpoint occurs<br>n = 3,506+?)
    
    D4 --> D5{Indapamide<br>vs HCTZ<br>α1 = α/2}
    E4 --> D5
    E4 --> E5{Chlorthalidone<br>vs HCTZ<br>α1 = α/2}
    F4 --> E5
    
    D5 --> D6(Ho)
    D5 --> F6(Ha)
    E5 --> E6(Ho)
    E5 --> G6(Ha)
    
    D6 --> D7[No Test]
    E6 --> D7
    F6 --> F7[Chlorthalidone<br> vs indapamide<br>α2 = α]
    G6 --> F7
    D6 --> E7[Chlorthalidone<br> vs indapamide<br>ɑ2 = 0.0125]
    G6 --> E7
    E6 --> G7[Chlorthalidone<br> vs indapamide<br>ɑ2 = 0.0125]
    F6 --> G7
    
  subgraph Allocation
    direction LR
    I
    D1
    E1
    F1
  end
    
  subgraph Followup
    direction LR
    J
    D2
    E2
    F2
  end
    
  subgraph Analysis
    direction LR
    K
    D3
    E3
    F3
  end
    
  subgraph Endpoints
    direction LR
    L
    D4
    E4
    F4
  end
    
  subgraph Family 1 Tests
    direction LR
    M
    D5
    E5
  end
    
  subgraph Family 2 Tests
    direction LR
    N
    D7
    subgraph ɑ2
      direction LR
      E7
      G7
    end
    F7
  end
  
  style C fill:#e20000,stroke:#333,stroke-width:4px
  style D5 fill:#e20000,stroke:#333,stroke-width:4px
  style E5 fill:#e20000,stroke:#333,stroke-width:4px
  
  style H fill:#00AFBB,stroke:#333,stroke-width:4px
  style I fill:#00AFBB,stroke:#333,stroke-width:4px
  style J fill:#00AFBB,stroke:#333,stroke-width:4px
  style K fill:#00AFBB,stroke:#333,stroke-width:4px
  style L fill:#00AFBB,stroke:#333,stroke-width:4px
  style M fill:#00AFBB,stroke:#333,stroke-width:4px
  style N fill:#00AFBB,stroke:#333,stroke-width:4px
```
